skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

918 Total results for product and free and sample content found

Medtech Insight

Start-Up Spotlight: Saluda Hopes To 'Evoke' From Down Under With First Closed-Loop Spine-Stim System

By Bob Kronemyer 16 Feb 2018

Aiming to improve the lives of patients living with chronic, intractable pain, Australian startup Saluda Medical Pty Limited is the first and only neuromodulation company in the world to develop a closed-loop spinal cord stimulation system (SCS). Unlike other SCS systems marketed today, Saluda’s device, currently in clinical trials, is designed to measure the spinal cord’s response to electrical stimulation, and then respond to patient's preferred stimulation.

Pink Sheet

Alzheimer's Biomarkers Gain Prominence In Drug Development Guidance

By Brenda Sandburg 16 Feb 2018

US FDA revises draft guidance issued in 2013 to allow research targeting cognition as single endpoint and studies solely evaluating biomarkers; document offers 'potential for multiple advances,' Alzheimer's Association says.

Topic Alzheimers


Workforce Roundtable Part 1 Recruiting Biopharma Leaders As The Talent Pool Shrinks

By Mandy Jackson 13 Feb 2018

As Baby Boomers age out of the workforce, they'll be replaced in biopharma C-suites and boardrooms by a younger, more female and racially diverse group. A panel of current and former life science CEOs, venture investors and recruiters discuss the challenges and opportunities ahead.

Topic Business strategies

In Vivo

Repositioning Market Access A Function Fit For Purpose In A New Era Of Costly Cures

By William Looney 13 Feb 2018

On October 5, In Vivo convened a group of top market-access specialists and industry and investment analysts to consider a central strategic challenge facing all innovators in biopharma: how to pay for the next wave of cures. Finding the answer first depends on a rebranding of the function itself – it’s not market access to products; it’s patient access to progress.

Topic Strategy


Pharma Q4 Results Preview

By Lucie Ellis 13 Feb 2018

Potential upheavals in the hemophilia market bring uncertainty for Shire and Bayer, with executives likely to be quizzed on how they can retain market share during upcoming Q4 results calls. Scrip’s final earnings preview highlights the key challenges for large companies reporting at the tail-end of the earnings season.


Meddevicetracker Weekly Roundup 12-02-18

12 Feb 2018

In this weeks roundup, Amiko receives CE Mark for three novel inhaler sensors, PolarityTE provides updates on the clinical use of SkinTE, Abbott launches FreeStyle LibreLink App in Europe, and much more

Topic Medtech weekly roundup


Informa Pharma Intelligence’s Citeline API Works with Saama to Deliver Unprecedented Insight into Clinical Trials

12 Feb 2018

Citeline leveraging Saama’s artificial intelligence to offer customers a complete understanding of the clinical trial landscape

Medtech Insight

Venture financing activity hit the ground running in 2018

By Tina Tan 12 Feb 2018

Venture financing activity hit the ground running in 2018 after a bumper haul of mega-raises brought the total deal value for January close to $1bn.

Topic Business strategies


Hong Kong Takes On Nasdaq For China Biotech IPOs

By Brian Yang 09 Feb 2018

Hong Kong is catching global attention as it plans to drastically change listing rules for biotech firms, potentially opening the way to both Chinese companies seeking public funding and international firms eyeing entry to China. A Shanghai biosimilars developer, among others, is now eyeing an offering.

Topic Policy and regulation

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: